Request an Invitation
CardioExchange has 4,577 members
Reanalyzed Chantix Data Yield Smaller CV Risk, New Controversy
A new meta-analysis criticizes earlier work warning that the smoking-cessation drug varenicline (Chantix) poses increased cardiovascular risks. The an...
To continue reading, please log in to the right or
request an invitation
Member Sign In
Stay Signed In
Forgot your password?
Request an invitation
to become a CardioExchange member.
Copyrighted © 2013, Massachusetts Medical Society
The content of this site is intended for health care professionals.